Table 1 Preoperative and pathologic characteristics of men younger than 50 undergoing RP (n = 650)
Black N = 99 | White N = 551 | p-value | |
|---|---|---|---|
Preoperative characteristics | |||
Age at surgery | 47 (45, 48) | 47 (45, 49) | 0.08 |
Preoperative PSA | 6.1 (4.0, 8.3) | 4.7 (3.0, 6.7) | 0.004 |
Biopsy Gleason score | 0.3 | ||
≤6 | 51 (53%) | 329 (61%) | |
7 | 38 (40%) | 177 (33%) | |
≥8 | 7 (7%) | 31 (6%) | |
Clinical Stage | 0.03 | ||
T0, T1a, T1b | 1 (1%) | 3 (1%) | |
T1c | 76 (78%) | 347 (63%) | |
T2a | 11 (11%) | 113 (21%) | |
T2b | 7 (7%) | 45 (8%) | |
≥T2c | 2 (2%) | 31 (7%) | |
Charlson comorbidity score | 0.04 | ||
≤2 | 5 (5%) | 20 (4%) | |
3-5 | 73 (74%) | 463 (84%) | |
≥6 | 21 (21%) | 68 (12%) | |
Pathologic characteristics | |||
Pathologic Gleason score | 0.6 | ||
≤6 | 35 (35%) | 219 (40%) | |
7 | 58 (59%) | 294 (54%) | |
≥8 | 6 (6%) | 30 (6%) | |
Extracapsular extension | 14 (14%) | 124 (23%) | 0.06 |
Lymph node involvement | 0.4 | ||
Positive | 2 (2%) | 28 (5%) | |
Negative | 88 (89%) | 483 (88%) | |
Not performed | 9 (9%) | 40 (7%) | |
Seminal vesicle invasion | 5 (5%) | 25 (5%) | 0.8 |